1. Home
  2. CRVL vs SLNO Comparison

CRVL vs SLNO Comparison

Compare CRVL & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CorVel Corp.

CRVL

CorVel Corp.

HOLD

Current Price

$56.91

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Logo Soleno Therapeutics Inc.

SLNO

Soleno Therapeutics Inc.

HOLD

Current Price

$52.75

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRVL
SLNO
Founded
1987
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.3B
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
CRVL
SLNO
Price
$56.91
$52.75
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$83.00
AVG Volume (30 Days)
178.5K
6.2M
Earning Date
05-21-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
108.90
EPS
1.53
0.39
Revenue
$895,589,000.00
$1,450,788.00
Revenue This Year
N/A
$150.46
Revenue Next Year
N/A
$50.37
P/E Ratio
$37.06
$135.31
Revenue Growth
12.61
138.82
52 Week Low
$44.83
$29.43
52 Week High
$117.22
$89.12

Technical Indicators

Market Signals
Indicator
CRVL
SLNO
Relative Strength Index (RSI) 59.43 76.80
Support Level $51.10 $48.91
Resistance Level $71.89 $55.47
Average True Range (ATR) 1.79 0.16
MACD 0.29 0.04
Stochastic Oscillator 88.68 79.85

Price Performance

Historical Comparison
CRVL
SLNO

About CRVL CorVel Corp.

CorVel Corp applies technology including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies, and government agencies in managing worker's compensation and health, auto, and liability services. The company's solutions combine integrated technologies with a human touch providing services that include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care, and medicare services.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: